CJC-1295 with DAC

CJC-1295 with DAC – Long-Acting GHRH Analogue Research Peptide

CJC-1295 with DAC is a synthetic Growth Hormone–Releasing Hormone (GHRH) analogue modified with a Drug Affinity Complex (DAC) to significantly prolong its half-life. In laboratory studies, this peptide is used to investigate the sustained stimulation of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) through interaction with GHRH receptors.

This peptide is produced in accordance with strict laboratory standards and verified via High-Performance Liquid Chromatography (HPLC) to ensure a purity of ≥99%. It is supplied in a stable lyophilized form for use in controlled endocrinological and biochemical research applications.

A batch-specific Certificate of Analysis (CoA) is available on request and accompanies every order. Sealed lyophilizate. Shelf life 24 months from manufacture.

Key Specifications

• Name: CJC-1295 with DAC (Drug Affinity Complex)
• Molecular Formula: C165H271N47O46
• Molecular Weight: ≈ 3647.1 Da
• Form: Lyophilized Powder
• Purity: ≥99% (HPLC tested)
• Storage: Store refrigerated, protected from light and moisture

Research Applications

• Studied in the context of long-term stimulation of GH and IGF-1 secretion in in-vitro assay systems.
• Examined in endocrinological and receptor signalling research as a reference reagent.
• Extended half-life supports investigations into growth hormone regulation and GHRH receptor pharmacology.
• Lyophilized format allows for stable storage and precise laboratory handling.